AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found during stability testing at a 3rd party lab. Risk Statement: In the population most at risk, immunocom | ||||
Tags: Recalls AvKARE LLC. Issues Voluntary Nationwide Recall Atovaquone Oral Suspension USP 750 mg/5 Due Potential Bacillus Cereus Contamination | ||||
Rating: 0.00 (0 votes) Rate this article | ||||
Bookmark and share this news item: |
Enter comment